Lv610
1630 积分 2023-06-06 加入
The predict factors and clinical prognosis value of immune-related pneumonia of receiving PD-1 inhibitor in advanced non-small cell lung cancer: A retrospective study
12天前
已完结
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
19天前
已完结
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
19天前
已完结
The Chemical Society (of London) after one hundred years
20天前
已关闭
Bevacizumab-Induced Hypertension
23天前
已完结
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
23天前
已完结
Characteristic morphological changes in anti‐VEGF therapy‐induced glomerular microangiopathy
23天前
已完结
Clinicopathological analysis of anti-VEGF drug-associated renal thrombotic microangiopathy: A case series and review of the literature
23天前
已完结
Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence
23天前
已完结
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1个月前
已完结
皖公网安备34019202002308
